| Month |
Publication |
Title |
| November |
The Hindu |
Orchid's growth plans |
| November |
The Financial Express |
Orchid Chemicals targets $1bn turnover |
| November |
Business Line |
Orchid Chem eyes $1-b turnover |
| November |
The Economic Times |
Orchid identifies lifestyle drugs as its thrust
area |
| September |
The Economic Times |
Orchid completes clinical trials of anti-diabetic
molecule |
| September |
Business Standard |
Aiming high |
| September |
Business Standard |
Orchid
seeks ally for product development |
| August |
The Financial Express |
Orchid
Files 7th ANDA |
| July |
The Economic Times |
Orchid
banks on regulated markets |
| July |
The Economic Times |
Orchid
gears up to enter US, European markets |
| July |
The Economic Times |
Suitability
certificate for Orchid product |
| June |
The Economic Times |
Orchid
plans clinical research foray |
| June |
Business Line |
Orchid
extends deal with Apotex |
| June |
The Economic Times |
Orchid
to file 15 new drug applications in US |
| June |
The Economic Times |
Orchid
enters Canada |
| May |
Business Standard |
Orchid
in marketing tie-up with Par Pharma |
| May |
The Financial Express |
Orchid
Chemicals In Marketing Deal With Par Pharma Of US |
| May |
The Economic Times |
Orchid
in tie-up with Par of US |
| May |
Business Standard |
We
should be valued higher |
| May |
The Financial Express |
Orchid
Pharma Files ANDA For Sterile Formulation Product |
| April |
Business Line |
Orchid
Chem gets nod to raise $75 m thru FCCBs |
| April |
The Financial Express |
Orchid
Offers Warrants To Promoters At A Discount |
| April |
The Economic Times |
Orchid
identifies 15 antibiotics for US foray |
| April |
The Economic Times |
FIIs
want a bigger share of Orchid |
| March |
The Financial Express |
Orchid's
tonic For Growth |
| March |
The Economic Times |
Orchid
Chemicals' IPR filings count touches 200 |
| March |
The Economic Times |
Orchid
to raise $75m via FCCBs |
| March |
The Financial Express |
Orchid
to Raise $75 Mn To Fund Growth Plans |
| March |
The Hindu |
Orchid
to raise $75 m through FCCBs |
| February |
Business Line |
|
| January |
Business Line |
Human
trials on Orchid's new anti-inflammatory drug in June |
| January |
The New Indian Express |
Orchid
Q3 net jumps 126 per cent |
| January |
Business Standard |
Orchid
Q3 net zooms 126% |
| January |
The Hindu |
Orchid's
unit bags ISO 14001, OHSAS 18001 |
| January |
The Economic Times |
|
